Literature DB >> 20836623

Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.

Nicolas Duceppe1, Maryam Tabrizian.   

Abstract

IMPORTANCE OF THE FIELD: This review aims to provide an overview of state-of-the-art chitosan-based nanosized carriers for the delivery of therapeutic agents. Chitosan nanocarriers are smart delivery systems owing to the possibility of their property alterations with various approaches, which would confer them with the possibility of spatiotemporal delivery features. AREAS COVERED IN THIS REVIEW: The focus of this review is principally on those aspects that have not often been addressed in other reviews. These include the influence of physicochemical properties of chitosan on delivery mechanisms and chitosan modification with a variety of ligand moieties specific for cell surface receptors to increase recognition and uptake of nanocarriers into cells through receptor-mediated endocytosis. Multiple examples that demonstrate the advantages of chitosan-based nanocarriers over other delivery systems of therapeutic agents are highlighted. Particular emphasis is given to the alteration of material properties by functionalization or combination with other polymers for their specific applications. Finally, structural and experimental parameters influencing transfection efficiency of chitosan-based nanocarriers are presented for both in vitro and in vivo gene delivery. WHAT THE READER WILL GAIN: The readers will acquire knowledge of parameters influencing the properties of the chitosan-based nanocarriers for delivery of therapeutic agents (genetic material or drugs) in vitro and in vivo. They will get a better idea of the strategies to be adapted to tune the characteristics of chitosan and chitosan derivatives for specific delivery applications. TAKE HOME MESSAGE: Chitosan is prone to chemical and physical modifications, and is very responsive to environmental stimuli such as temperature and pH. These features make chitosan a smart material with great potential for developing multifunctional nanocarrier systems to deliver large varieties of therapeutic agents administrated in multiple ways with reduced side effects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20836623     DOI: 10.1517/17425247.2010.514604

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  25 in total

Review 1.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

2.  A Low Protein Binding Cationic Poly(2-oxazoline) as Non-Viral Vector.

Authors:  Zhijian He; Lei Miao; Rainer Jordan; Devika S-Manickam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Macromol Biosci       Date:  2015-04-02       Impact factor: 4.979

3.  In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  J Pharm Sci       Date:  2013-12-30       Impact factor: 3.534

Review 4.  When 1+1>2: Nanostructured composites for hard tissue engineering applications.

Authors:  Vuk Uskoković
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-08-01       Impact factor: 7.328

5.  Advances in Integrative Nanomedicine for Improving Infectious Disease Treatment in Public Health.

Authors:  Iris R Bell; Gary E Schwartz; Nancy N Boyer; Mary Koithan; Audrey J Brooks
Journal:  Eur J Integr Med       Date:  2013-04-01       Impact factor: 1.314

Review 6.  Application of chitosan-based nanocarriers in tumor-targeted drug delivery.

Authors:  Mohammad Ali Ghaz-Jahanian; Farzin Abbaspour-Aghdam; Navideh Anarjan; Aydin Berenjian; Hoda Jafarizadeh-Malmiri
Journal:  Mol Biotechnol       Date:  2015-03       Impact factor: 2.695

7.  Development of a low toxicity, effective pDNA vector based on noncovalent assembly of bioresponsive amino-β-cyclodextrin:adamantane-poly(vinyl alcohol)-poly(ethylene glycol) transfection complexes.

Authors:  Aditya Kulkarni; Wei Deng; Seok-hee Hyun; David H Thompson
Journal:  Bioconjug Chem       Date:  2012-05-02       Impact factor: 4.774

8.  Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.

Authors:  Dhruba J Bharali; Murat Yalcin; Paul J Davis; Shaker A Mousa
Journal:  Nanomedicine (Lond)       Date:  2013-02-28       Impact factor: 5.307

9.  Simultaneous delivery of anti-miRNA and docetaxel with supramolecular self-assembled "chitosome" for improving chemosensitivity of triple negative breast cancer cells.

Authors:  Xianfu Sun; Haipeng Xu; Tao Huang; Chengjuan Zhang; Junzhao Wu; Suxia Luo
Journal:  Drug Deliv Transl Res       Date:  2021-02       Impact factor: 4.617

10.  Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.

Authors:  Darryl T Martin; Jill M Steinbach; Jingchun Liu; Shogo Shimizu; Hristos Z Kaimakliotis; Marcia A Wheeler; Adam B Hittelman; W Mark Saltzman; Robert M Weiss
Journal:  Mol Cancer Ther       Date:  2013-11-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.